Drug Hepatotoxicity, An Issue of Clinics in Liver Disease
- 1 Edición, Volumen 24-1 - 21 de noviembre de 2019
- Última edición
- Editor: Pierre Gholam
- Idioma: Inglés
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of… Leer más
Descripción
Descripción
In collaboration with Consulting Editor, Dr. Norman Gitlin, Dr. Pierre Gholam has put together topics that provide a current clinical update on the treatment and management of patients with drug-induced liver injury (DILI). Expert authors have contributed clinical review articles on the following topics: Epidemiology, Predisposing Factors and Outcomes; Genetic Predisposition to DILI; Causality Assessment Frequent Offenders and Patterns of Injury; Quantitative Systems Toxicology Approaches to Understand and Predict DILI; Liver Histology: Diagnostic and Prognostic Features; Acute Liver Failure Secondary to DILI; DILI in Persons with Pre-existing Chronic Liver Disease; DILI in the Setting of Statin Use; DILI in the Setting of Analgesic Use; DILI Secondary to Herbals and Dietary Supplements; and DILI Reporting and Resources for the Clinician. Readers will come away with the information they need to improve outcomes in patients with DILI.
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 24-1
- Publicado: 21 de noviembre de 2019
- Idioma: Inglés
Sobre el editor
Sobre el editor
PG
Pierre Gholam
Afiliaciones y experiencia
Professor of Medicine, Case Western Reserve University School of Medicine, Medical Director, Liver Center of Excellence, University Hospitals of Cleveland